<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00965380</url>
  </required_header>
  <id_info>
    <org_study_id>CP-01006B</org_study_id>
    <nct_id>NCT00965380</nct_id>
  </id_info>
  <brief_title>Trinity Evolution in Posterior or Transforaminal Lumbar Interbody Fusion (PLIF/TLIF)</brief_title>
  <acronym>TLF</acronym>
  <official_title>A Radiographic and Clinical Study Evaluating a Novel Allogeneic, Cancellous, Bone Matrix Containing Viable Stem Cells (Trinity Evolutionâ„¢ Viable Cryopreserved Cellular Bone Matrix) in Posterior Lumbar or Transforaminal Lumbar Interbody Fusion (PLIF or TLIF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orthofix Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orthofix Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to utilize Trinity Evolution in conjunction with an interbody&#xD;
      spacer and supplemental posterior fixation of the surgeon's choice and to follow the patients&#xD;
      to measure the clinical outcomes and rate of fusion. The hypothesis of the study is that&#xD;
      Trinity Evolution combined with an interbody spacer and supplemental posterior fixation will&#xD;
      result in fusion rates and clinical outcomes similar to those with other routinely used&#xD;
      autograft and allograft materials including: fusion, improvement in pain and function,&#xD;
      maintenance of lower extremity neurological function, and absence of serious adverse events&#xD;
      related to the use of the Trinity Evolution product.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Degenerative disorders of the lumbar spine can lead to a multitude of clinical problems&#xD;
      including back pain and/or leg pain secondary to nerve compression and/or deformity. When&#xD;
      conservative (non-surgical) treatment fails after at least a 6 month period and/or&#xD;
      non-operative treatment is not indicated, patients and physicians may turn to a surgical&#xD;
      solution. Surgical options consist basically of decompressing nerves, correcting and/or&#xD;
      stabilizing deformities if required and fusing the segment, depending on the clinical&#xD;
      situation. The &quot;gold standard&quot; for aiding healing in spinal fusion surgeries is the&#xD;
      harvesting of autograft from the patient's iliac crest and placing it in and around the&#xD;
      segments of the spine that are intended to be fused. Autograft is considered the &quot;gold&#xD;
      standard&quot; because it contains the essential elements required for successful bone grafting:&#xD;
      osteogenesis, osteoconduction, and osteoinduction.&#xD;
&#xD;
      However, the morbidity of harvesting autograft has been well documented and includes chronic&#xD;
      donor-site pain, infection, neurologic injury, blood loss, deformity, bowel injury, hernia,&#xD;
      and prolonged surgical and hospitalization time. There are now a number of products on the&#xD;
      market to minimize or replace the use of autograft. However, few of these products contain&#xD;
      all three essential bone-forming elements (osteogenesis, osteoconduction, and osteoinduction)&#xD;
      in a single, stand alone product.&#xD;
&#xD;
      Trinity Evolution is a novel, allogeneic cancellous bone matrix containing viable&#xD;
      osteoprogenitor cells, mesenchymal stem cells and a demineralized cortical bone (DCB)&#xD;
      component to provide the required osteoconduction, osteogenesis, and osteoinduction necessary&#xD;
      for successful bone grafting. Preclinical studies with Trinity Evolution have demonstrated&#xD;
      in-vitro and in-vivo safety and effectiveness. Trinity Evolution is considered an allograft&#xD;
      and as such is a &quot;minimally manipulated&quot; tissue and is labeled for bone repair for spinal,&#xD;
      orthopedic and podiatric indications where autograft is used. The dosage will be dependent&#xD;
      upon the specific requirements of the case.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion Rates for Trinity Evolution</measure>
    <time_frame>Operative to 24 months follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>NDI relative improvement; VAS improvement; Maintenance or improvement of neurological function</measure>
    <time_frame>Pre-op to 24 months follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication Rates for Trinity Evolution</measure>
    <time_frame>Operative to 24 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">207</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with symptomatic lumbar degenerative disc disease scheduled to undergo PLIF or&#xD;
        TLIF.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptomatic lumbar degenerative disc disease at 1 or 2 adjacent levels between L3 and&#xD;
             S1&#xD;
&#xD;
          -  Patients with back and/or leg pain scheduled for stabilization with or without&#xD;
             decompression via a TLIF or PLIF approach utilizing an interbody spacer and&#xD;
             supplemental posterior fixation.&#xD;
&#xD;
          -  Greater than 18 years of age&#xD;
&#xD;
          -  Unresponsive to conservative care over a period of at least 6 months or has&#xD;
             progressive neurological signs and/or symptoms of neurological compromise that mandate&#xD;
             urgent surgical intervention&#xD;
&#xD;
          -  Willing and able to comply with the requirements of the protocol including follow-up&#xD;
             requirements&#xD;
&#xD;
          -  Willing and able to sign a study specific informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients requiring surgical treatment other than at 1 or 2 adjacent levels between L3&#xD;
             and S1&#xD;
&#xD;
          -  Active local or systemic infection&#xD;
&#xD;
          -  Currently pregnant or considering becoming pregnant during the follow-up period&#xD;
&#xD;
          -  Active malignancy or having been on chemotherapy of any kind for a malignancy in the&#xD;
             past 1 year&#xD;
&#xD;
          -  Use of any other bone graft or bone graft substitute in addition to or in place of&#xD;
             Trinity Evolution matrix in and around the interbody spacer.&#xD;
&#xD;
          -  Use of adjunctive post-operative stimulation&#xD;
&#xD;
          -  Prior interbody surgery at the same level&#xD;
&#xD;
          -  Has a known history of hypersensitivity or anaphylactic reaction to dimethyl sulfoxide&#xD;
             (DMSO).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James T Ryaby, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Orthofix Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boulder Neurosurgical Associates</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Total Spine Care</name>
      <address>
        <city>Canton</city>
        <state>Connecticut</state>
        <zip>06019</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Middlesex Orthopedic Surgeons</name>
      <address>
        <city>Middletown</city>
        <state>Connecticut</state>
        <zip>06457</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Advanced Neuro and Spine</name>
      <address>
        <city>New Britain</city>
        <state>Connecticut</state>
        <zip>06051</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Optim Healthcare (Formerly Southeastern Orthopedic Center)</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkview Orthopaedic Group</name>
      <address>
        <city>Palos Heights</city>
        <state>Illinois</state>
        <zip>60463</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Willis Knighton Health System</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan A. Alfred Taubman Health Care Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper University Neurological Institute</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spine Surgery of Buffalo Niagara</name>
      <address>
        <city>Niagara Falls</city>
        <state>New York</state>
        <zip>14304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina NeuroSurgery &amp; Spine</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Triangle Orthopaedic Associates</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Triangle Neurosurgery</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tuckahoe Orthopedic Surgeons</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>August 21, 2009</study_first_submitted>
  <study_first_submitted_qc>August 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2009</study_first_posted>
  <last_update_submitted>October 21, 2018</last_update_submitted>
  <last_update_submitted_qc>October 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Trinity Evolution</keyword>
  <keyword>Symptomatic lumbar degenerative disc disease</keyword>
  <keyword>Posterior lumbar interbody fusion</keyword>
  <keyword>Transforaminal lumbar interbody fusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

